First Global Reiterates Moderate Outperform Rating on Pfizer

First Global Research has published a research report on Pfizer Inc PFE. In the report, First Global wrote, "Pfizer Inc. (PFE) delivered a respectable performance for Q2 CY11 that met our expectations. The company's non-GAAP EPS of 60 cents for the quarter came in line with our estimate, driven by a decent topline performance, as well as its ongoing cost control and rationalization measures. Management also kept its guidance for both CY11 and CY12 unchanged." First Global rated Pfizer a Moderate Outperform with no price target given. Pfizer closed Monday at $17.68.